Jun 27 |
Biotricity, Inc. (BTCY) Q4 2024 Earnings Call Transcript
|
Jun 27 |
Biotricity GAAP EPS of -$0.47, revenue of $3.2M in-line
|
Jun 27 |
Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability
|
Jun 26 |
Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27
|
Jun 12 |
Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market
|
May 30 |
Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
|
Apr 26 |
Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
|
Apr 16 |
Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network
|
Apr 2 |
Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities
|
Mar 28 |
LOBO EV and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|